The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)

NCT06921486 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1003

Enrollment

OTHER

Sponsor class

Conditions

Obesity and Overweight

Interventions

DRUG: Phase IIb：Efsubaglutide Alfa 5 mg QW
DRUG: Phase IIb：Efsubaglutide Alfa 10 mg QW
DRUG: Phase IIb：Efsubaglutide Alfa 20 mg QW
DRUG: Phase IIb：Efsubaglutide Alfa 20 mg Q2W
DRUG: Phase IIb：Placebo
DRUG: Phase III：Recommended Phase 3 Dose High Dose
DRUG: Phase III：Recommended Phase 3 Dose Low Dose
DRUG: Phase III：Placebo

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.